Aletta Falk - Global Med Affairs & Clin Sci, Sobi

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 13 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety and Efficacy of SEL-212 in the US and Ex-Us Subgroups: Results from the Phase 3 DISSOLVE Studies

Michael Pillinger,Alan Kivitz,Atul Singhal, Anand Patel,Rehan Azeem,Aletta Falk, Bhavisha Desai, Hugues Santin-Janin,Herbert Baraf

ARTHRITIS & RHEUMATOLOGY (2024): 4100-4102

引用0浏览0引用

Efficacy and Safety of SEL-212 in Patients with Refractory Gout and CKD: A Post Hoc Analysis from the Two Phase 3 DISSOLVE Studies

Puja Khanna, Richard J. Johnson,Rehan Azeem,Aletta Falk, Bhavisha Desai, Hugues Santin-Janin,Herbert Baraf,Alan J. Kivitz

Journal of the American Society of Nephrologyno. 10S (2024)

引用0浏览0引用

COST-EFFECTIVENESS OF RECOMBINANT FACTOR IX FC PROPHYLAXIS AND RECOMBINANT FACTOR IX ONDEMAND TREATMENT IN PATIENTS WITH HAEMOPHILIA B WITHOUT INHIBITORS

Michal Pochopien, Anna Tytuła,Mondher Toumi,Aletta Falk, Nicoletta Martone,Zalmai Hakimi,Daniel Eriksson

Advances in Therapy（2024）

引用0浏览0WOS引用

Impact of Anti-drug Antibodies on the Efficacy of SEL-212 in Patients with Chronic Gout Refractory to Conventional Therapy

Puja Khanna,Vibeke Strand,Atul Singhal,Herbert Baraf,Rehan Azeem,Wesley DeHaan,Sheldon Leung, Hugues Santin-Janin,Aletta Falk,Alan Kivitz

ARTHRITIS & RHEUMATOLOGY (2024): 4077-4079

引用0浏览0引用

An Observational Study of Haemophilia A Patients Without Inhibitors Using the French National Claims (SNDS) Database

Marc Trossaert,Aletta Falk,Laurene Gautier,Nana Kragh, Olivia Van Hinloopen,Remi Varin

Hematologyno. 1 (2024)

引用0浏览0WOS引用

Improvements in Patient-Reported Outcomes after Treatment with SEL-212 in Adults with Refractory Gout: Results from Two Randomized Phase 3 Trials

Vibeke Strand,Puja Khanna,Alan Kivitz,Nana Kragh,Aletta Falk,Rehan Azeem, Hugues Santin-Janin,Herbert Baraf

ARTHRITIS & RHEUMATOLOGY (2024): 700-703

引用0浏览0引用

Prophylaxis with Recombinant Factor IX Fc Fusion Protein Reduces the Risk of Bleeding and Delays Time to First Spontaneous Bleed Event in Previously Untreated Patients with Haemophilia B: A Post Hoc Analysis of the PUPs B-LONG Study

Beatrice Nolan,Michael Recht,Pablo Rendo,Aletta Falk,Meredith Foster,Sandra Casiano,Antoine Rauch,Amy Shapiro

European Journal Of Haematology（2024）

引用0浏览0WOS引用

Efficacy of Rfixfc Versus N9-GP Prophylaxis in Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PARADIGM 2 Trials

Maria Elisa Mancuso,Daniel Eriksson,Aletta Falk,Zalmai Hakimi,Piotr Wojciechowski,Marlena Wdowiak,Robert Klamroth

JOURNAL OF BLOOD MEDICINE（2023）

引用0浏览0WOS引用

Real-World Effectiveness of Rfixfc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries

Eva Funding,Gillian Lowe,Lone H. Poulsen,Susan Shapiro,Johannes Oldenburg,Daniel Eriksson,Aletta Falk,Carly Rich

ADVANCES IN THERAPYno. 9 (2023): 3770-3783

引用5浏览0WOS引用

Recombinant Factor IX Fc Prophylaxis Reduces Pain and Increases Levels of Physical Activity, with Sustained, Long-Term Improvements in Patients with Hemophilia B: Post Hoc Analysis of Phase III Trials Using Patient-Reported Outcomes

Jan Astermark,Cedric Hermans,Monia Ezzalfani, Alaeddine Sidhom, Sylvaine Barbier,Nana Kragh,Aletta Falk,Daniel Eriksson

THERAPEUTIC ADVANCES IN HEMATOLOGY (2023)

引用2浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn